Patient Education in the Clinical Management of Pessary
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · May 22, 2024
Trial Information
Current as of March 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Symptomatic pelvic organ prolapse of stage II\~IV
- • Ability to participate in clinical trial and follow-up
- • The patient and family understand the study, are willing to participate in the 1-year study, and provide written informed consent
- Exclusion Criteria:
- • Acute phase of infection of the internal and/or external genital tracts
- • Genital fistula
- • Suspected or untreated lower genital tract tumors
- • Abnormally elevated intra-abdominal pressure (e.g., ascites, tumors)
- • Life expectancy less than 1 year
- • Cognitive or language communication disorders
- • Unable to watch video (e.g., blindness)
Trial Officials
Lan Zhu, MD
Principal Investigator
Peking Union Medical College Hospital
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
